Chad E. Davis, Ph.D.

Chad E. Davis, Ph.D. counsels companies, investors, and entrepreneurs on intellectual property matters, especially patent matters. Dr. Davis has extensive experience in prosecution and strategic development of worldwide patent portfolios, intellectual property due diligence, risk assessment through, for example, validity and infringement analyses, post-grant patent proceedings, and intellectual property contracts.

Dr. Davis represents clients in a diverse range of technologies, including pharmaceuticals, drug delivery technologies, crystal forms, organic dyes, chemical processes, polymers, proteins, antibodies, stem cell technology, medical diagnostics, medical imaging, microfluidic devices, adhesives, analytical chemistry, foams, cosmetics, and optical technologies.  For companies developing pharmaceuticals, Dr. Davis provides counsel through all aspects of the business cycle with particular acumen for developing and implementing strategies to maximize worldwide patent and regulatory exclusivities for the pharmaceutical product.

In 2024 and 2023, Dr. Davis was named a Leading Lawyer by The Legal 500 US for Intellectual Property: Patents: Prosecution, being described as having “a business-centric approach to IP, incorporating business strategy in his recommendations on patent prosecutions”. He is routinely recognized as an IAM Patent 1000 World’s Leading Patent Practitioner in Massachusetts, who in 2024, described him as “another impressive name for patent strategy and due diligence work”, whose “background in chemistry establishes him as a partner to life sciences industry players.” In 2023, IAM described Dr. Davis as someone who “thinks holistically on how to protect his clients’ IP” and “has an excellent grasp of the science, but also knows how to use this knowledge to achieve his clients’ business goals.” In 2022, IAM praised him as someone who "works creatively and pragmatically and has exceptional analytical skills, great strategic vision and a gift for communicating complex IP insights so they are easy to understand." In 2021, IAM referred to Dr. Davis as "another go- to in Boston and an essential partner to drug companies throughout all phases of the product development lifecycle." In 2019, Dr. Davis was recognized by The Legal 500 US for Industry focus: Healthcare: Life Sciences. Dr. Davis was also recognized by the National Law Journal as a "Rising Star" in the Boston area.